Ardelyx Q2 revenue $97.7M (+33%), raises IBSRELA guidance; CFO to depart

ARDELYX, INC.

2025-Q2 EPS reported -$0.25 revenue$171,776,000

Q2 total revenue $97.7M (+33% YoY); IBSRELA net sales $65M (+84% YoY); XPHOZAH net sales $25M (-33% YoY).
Raised FY2025 IBSRELA U.S. net sales revenue outlook to $250-260M from prior guidance.
Net loss $19.1M ($0.08/sh) vs $16.5M ($0.07) YoY; cash & investments $238.5M at June 30, 2025.
CFO Justin Renz to transition out by Dec 31, 2025 or upon new CFO start; transition agreement signed.
Drew $48.7M net from SLR term loan; option to draw additional $100M in two tranches.

item 2.02item 5.02item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.